Highlights,Northern Trust Corp increased its stake in GeneDx, now owning a notable portion of shares.,GeneDx reported quarterly revenue and earnings surpassing market estimates despite a negative net ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Fintel reports that on May 9, 2025, Jefferies upgraded their outlook for GeneDx Holdings (NasdaqGS:WGS) from Hold to Buy. Analyst Price Forecast Suggests 74.95% Upside As of May 7, 2025 ...

We introduce ACE-Step, a novel open-source foundation model for music generation that overcomes key limitations of existing approaches and achieves state-of-the-art performance through a holistic ...

On Friday, Jefferies analyst Tycho Peterson upgraded GeneDx stock, trading on (NASDAQ: WGS), from Hold to Buy, maintaining a price target of $80.00.The stock, currently trading at $56.36, has ...

4 analysts have expressed a variety of opinions on GeneDx Holdings (NASDAQ:WGS) over the past quarter, offering a diverse set of opinions from bullish to bearish. The table below provides a ...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings ...

On Friday, Jefferies analyst Tycho Peterson upgraded GeneDx stock, trading on (NASDAQ: WGS), from Hold to Buy, maintaining a price target of $80.00.The stock, currently trading at $56.36, has ...